CIK: 0001388551 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 14, 2020
Total Value ($000): $94,742 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MOLECULAR TEMPLATES INC | 2,107,991 | $29,069 | 30.7% | $8.09 | — | COM | 608550109 |
| — | STRONGBRIDGE BIOPHARMA PLC | 6,612,065 | $24,994 | 26.4% | $2.92 | — | SHS USD | G85347105 |
| CRDF | CARDIFF ONCOLOGY INC | 1,595,164 | $7,992 | 8.4% | $2.05 | 0.0% | COM | 14147L108 |
| — | SIERRA ONCOLOGY INC | 643,959 | $7,792 | 8.2% | $9.82 | — | COM NEW | 82640U404 |
| — | KALA PHARMACEUTICALS INC | 620,289 | $6,519 | 6.9% | $6.04 | — | COM | 483119103 |
| — | SCYNEXIS INC | 7,946,111 | $5,967 | 6.3% | $1.12 | — | COM | 811292101 |
| — | GARRISON CAP INC | 1,164,061 | $3,935 | 4.2% | $8.25 | — | COM | 366554103 |
| GLD | SPDR GOLD TR | 15,923 | $2,665 | 2.8% | $167.37 | — | GOLD SHS | 78463V107 |
| — | SATSUMA PHARMACEUTICALS INC | 68,172 | $1,961 | 2.1% | $15.01 | — | COM | 80405P107 |
| — | MEI PHARMA INC | 295,560 | $1,221 | 1.3% | $3.83 | — | COM NEW | 55279B202 |
| — | EIGER BIOPHARMACEUTICALS INC | 81,983 | $787 | 0.8% | $10.26 | — | COM | 28249U105 |
| — | CTI BIOPHARMA CORP | 619,460 | $719 | 0.8% | $1.19 | — | COM | 12648L601 |
| — | IVERIC BIO INC | 124,771 | $636 | 0.7% | $5.10 | — | COM | 46583P102 |
| KURA | KURA ONCOLOGY INC | 20,406 | $333 | 0.4% | $17.68 | -18.4% | COM | 50127T109 |
| — | ADDEX THERAPEUTICS LTD | 17,418 | $152 | 0.2% | $6.60 | — | SPONSORED ADS | 00654J107 |